Compensatory expression regulation of highly homologous proteins HNRNPA1 and HNRNPA2

Heterogeneous nuclear ribonucleoprotein (HNRNP) A1 and A2 are the most abundant HNRNPs with nearly identical functions, and play important roles in regulating gene expression at multiple levels (i.e. transcription, posttranscription, and translation). However, the expression and regulation mechanism of HNRNPA1 and A2 themselves remain unclear. In this study, the amino acid sequences of HNRNPA1 and HNRNPA2 were compared and found to have 78% and 86% homology in key functional domains. Transfection of HEK293 cells with small interfering RNA and overexpression vectors of HNRNPA1 and HNRNPA2 demonstrated that HNRNPA1 and HNRNPA2 paralogs regulate each other’s expression in a compensatory manner at both the RNA and protein levels. Multiprimer reverse transcription-polymerase chain reaction showed that HNRNPA1 and HNRNPA2 did not affect splicing of the HNRNPA2 and HNRNPA1 gene. Using luciferase reporting system, we found that compensatory degradation was mediated by the 3′UTR of the two genes rather than by the promoter. Moreover, treatment with cycloheximide inhibited the compensatory regulation. Our results indicate a novel regulation mechanism of HNRNPA1 and A2 expression. Through compensatory regulation, the expression levels of HNRNPA1 and HNRNPA2 are strictly controlled within a certain range to maintain normal cellular activities under different physiological conditions.

Keywords:

HNRNPA1, HNRNPA2 posttranscriptional gene regulation, 3′UTR, alternative splicing,

PDF

___

Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002
Bruun GH, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0279-9
BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x
Campillos M, 2003, NUCLEIC ACIDS RES, V31, P3063, DOI 10.1093/nar/gkg435
Carson JH, 2005, BIOL CELL, V97, P51 .
Chen YH, 2018, ONCOL REP, V39, P1693, DOI 10.3892/or.2018.6273
Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783
Fahling M, 2006, J BIOL CHEM, V281, P9279, DOI 10.1074/jbc.M510925200
Geissler R, 2016, GENE DEV, V30, P1070, DOI 10.1101/gad.277392.116
Han SP, 2010, RNA, V16, P1760, DOI 10.1261/rna.2142810
He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1
Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014
Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922
Li H, 2015, BIOMATERIALS, V63, P168, DOI 10.1016/j.biomaterials.2015.06.013
Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08
Liu TY, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160303
Liu XX, 2016, GENE, V576, P791, DOI 10.1016/j.gene.2015.11.009
Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8
MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x
Moran-Jones K, 2005, NUCLEIC ACIDS RES, V33, P486, DOI 10.1093/nar/gki203
Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304
Romero-Garcia S, 2014, EXP LUNG RES, V40, P12, DOI 10.3109/01902148.2013.856049
Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750
Suzuki H, 2017, MOL CELL BIOCHEM, V427, P123, DOI 10.1007/s11010-016-2904-x
Wang F, 2017, CELL RES, V27, P540, DOI 10.1038/cr.2017.7
Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806
Zhao S, 2008, MOL CELL NEUROSCI, V37, P69, DOI 10.1016/j.mcn.2007.08.015
Zhao TT, 2009, CELL DEATH DIFFER, V16, P244, DOI 10.1038/cdd.2008.146